The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
Journal
Human Vaccines and Immunotherapeutics
Journal Volume
14
Journal Issue
7
Pages
1779-1781
Date Issued
2018
Author(s)
SDGs
Other Subjects
aflatoxin; carcinogen; den; hepatitis B antibody; hepatitis B surface antigen; immunoglobulin G; unclassified drug; immunoglobulin; animal experiment; animal model; cancer incidence; carcinogenesis; clinical evaluation; hepatitis B; Hepatitis B virus; immunosuppressive treatment; Letter; liver carcinogenesis; liver tumor; mouse; nonhuman; nuclear magnetic resonance imaging; transgenic mouse; tumor volume; viremia; animal; Hepatitis B virus; immunology; liver cell carcinoma; liver tumor; male; viremia; virology; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Hepatitis B virus; Immunoglobulins; Liver Neoplasms; Male; Mice; Mice, Transgenic; Viremia
Publisher
Taylor and Francis Inc.
Type
letter